,32 Increased mTOR activity has been implicated in several glomerular diseases, such as membranous nephropathy, focal segmental glomerulosclerosis (FSGS), minimal change disease, and diabetic nephropathy.33 This evidence concerns the gene MTOR and lipoid nephrosis.